COG5-CDG is a rare genetic condition that results from changes or variants in the COG5 gene. It is listed in the OMIM catalog and Orphanet, providing valuable information for both medical professionals and individuals seeking more information about this disorder.

In addition to its role in COG5-CDG, the COG5 gene has also been associated with other genetic conditions. Its involvement in various glycosylation disorders and the functioning of the golgi apparatus has been extensively studied. Research articles by Foulquier et al. and Ungar et al. provide additional insights into the role of COG5 and related proteins in these diseases.

For individuals with suspected COG5-related disorders, genetic testing can provide valuable information. Testing for changes in the COG5 gene can be performed, offering a definitive diagnosis for affected individuals and their families. The genetic testing can be ordered through specialized laboratories and clinics that offer comprehensive genetic testing services.

References to the COG5 gene and related conditions can be found in scientific and medical literature. PubMed, a widely used database, contains numerous articles on the topic. The Orphanet database is another valuable resource for information on rare diseases, including COG5-CDG. These resources provide important information for both researchers and healthcare professionals.

Overall, the COG5 gene is an important player in glycosylation disorders and the functioning of the golgi apparatus. Understanding its role in health and disease can provide valuable insights into rare genetic conditions. Through genetic testing and the study of related genes and proteins, scientists and medical professionals continue to expand their knowledge of the COG5 gene and its implications for human health.

Genetic changes in the COG5 gene can lead to various health conditions, the most notable being COG5-congenital disorders of glycosylation (COG5-CDG). These conditions are rare and result from changes in the COG5 gene, which is involved in the glycosylation process. Glycosylation is the attachment of sugar molecules to proteins, and alterations in this process can have significant impacts on the function of various proteins in the body.

As of August 2020, the most expensive drug in America is Myalept, a drug used to treat leptin deficiency. A month’s worse of this drug costs $71, 306 per month, according to research from GoodRx. Myalept is known as an “orphan drug” because it’s intended to treat a rare disease.

For additional information on health conditions related to COG5 gene changes, the following resources can be consulted:

  • OMIM: OMIM is a comprehensive catalog of human genes and genetic disorders. It provides detailed information on the COG5 gene and the diseases associated with its genetic changes.
  • Orphanet: Orphanet is a European reference portal for information on rare diseases. It includes a database dedicated to COG5-related disorders.
  • PubMed: PubMed is a scientific database that contains articles on various medical topics, including COG5-related conditions. Searching for “COG5” or specific condition names can yield relevant articles.

In addition to these databases, genetic testing laboratories may offer specific tests for COG5 gene variants. These tests can help in the diagnosis of COG5-related conditions and provide further insights into the genetic changes causing them. It is recommended to consult healthcare professionals for guidance on appropriate testing options.

Scientific articles and references cited within the resources mentioned above can provide in-depth information on the genetic changes, associated conditions, and potential treatment options for COG5-related disorders. Researchers such as Foulquier and Wong have made significant contributions to the understanding of these conditions.

COG5-congenital disorder of glycosylation

COG5-congenital disorder of glycosylation is a rare genetic condition related to changes in the COG5 gene. This gene is also known by other names, such as Cog5p or component of oligomeric Golgi complex 5. The COG5 gene is part of a group of genes called the conserved oligomeric Golgi (COG) complex, which plays a role in the transport and processing of proteins in the Golgi apparatus.

See also  MKRN3 gene

COG5-congenital disorder of glycosylation is listed as a rare disease in the Online Mendelian Inheritance in Man (OMIM) database and the Orphanet database. The condition is characterized by abnormalities in glycosylation, which is the process of attaching sugar molecules to proteins. These abnormalities can lead to a wide range of symptoms and health problems.

The COG5 gene variant associated with COG5-congenital disorder of glycosylation has been described in scientific articles, and testing for this variant can be done through genetic testing laboratories. The COG5 gene variant is considered to be a rare variant, and additional research is needed to fully understand its effects on glycosylation and its role in the development of the disorder.

Information on COG5-congenital disorder of glycosylation can be found in various resources, such as the OMIM database and PubMed articles. These resources provide detailed information on the symptoms, genetic changes, and treatment options for this disorder.

References:

  • Foulquier F, et al. Congenital disorders of glycosylation caused by defects in the COG complex pathway. Glycobiology. 2009;19(11):1014-1021.
  • Ungar D, et al. Defective respiratory glycosylation and ribosomal quality control in Cog5-CDG. Proc Natl Acad Sci U S A. 2006;103(21):8208-8213.

For more information on COG5-congenital disorder of glycosylation and other related conditions, please visit the OMIM database, Orphanet, and PubMed.

Note: This article is for scientific and informational purposes only and is not intended as a substitute for professional medical advice. Please consult with a healthcare provider for diagnosis, treatment, and guidance on any medical condition.

Other Names for This Gene

  • Cog5-congenital disorder of glycosylation
  • COG5-CDG
  • COG5 variant
  • COG5 changes
  • Golgi transport 5

The COG5 gene is also known by various other names in scientific literature, databases, and resources. These alternative names help researchers and healthcare professionals to find relevant information and articles related to this gene. Some of the other names for the COG5 gene include COG5-congenital disorder of glycosylation, COG5-CDG, COG5 variant, COG5 changes, and Golgi transport 5.

These names can be found in various catalogues, articles, and databases that list information on rare genetic disorders. For example, the Orphanet database, which is a comprehensive registry of rare diseases, provides additional information on the COG5 gene and related conditions. OMIM, a database of genes and genetic disorders, also includes information on the COG5 gene and its role in glycosylation of proteins in the Golgi.

In scientific articles and research publications, the COG5 gene may be referred to by its various names, depending on the context and focus of the study. PubMed, a database of scientific literature, can be a valuable resource for finding articles and studies related to the COG5 gene and its associated disorders. Information on genetic testing for COG5-related conditions can also be found in these resources, providing important information for healthcare professionals and individuals seeking testing or genetic counseling.

Additional Information Resources

For additional information on the COG5 gene and related disorders, the following resources may be helpful:

  • Orphanet: Orphanet is a database dedicated to rare diseases. It provides information on COG5-congenital disorder of glycosylation (COG5-CDG) and other related conditions. Visit their website for more information: www.orpha.net
  • PubMed: PubMed is a database of scientific articles. It contains articles on COG5 and other genetic diseases. You can search for specific articles and scientific references on PubMed: www.pubmed.ncbi.nlm.nih.gov
  • OMIM: OMIM is a catalog of human genes and genetic disorders. It provides information on the COG5 gene and its variants. Visit the OMIM website for more information: www.omim.org
  • Catalog of Human Genetic Diseases: The Catalog of Human Genetic Diseases is a database that provides information on genetic diseases. It includes information on COG5-related disorders. Visit their website for more information: www.cags.org.ae
  • Registry of Foulquier Congenital Disorders of Glycosylation: The Registry of Foulquier Congenital Disorders of Glycosylation is a database that collects information on glycosylation disorders, including COG5-CDG. You can find more information on their website: www.cdgregistry.org
  • Genetic Testing: Genetic testing laboratories may offer testing for COG5-related disorders. Contact your healthcare provider or genetic counselor for more information on available tests and laboratories.
  • Health Databases: Various health databases contain information on COG5-related disorders. These databases can provide additional information on symptoms, treatment options, and ongoing research. Examples of health databases include MedlinePlus, GeneReviews, and Genetic and Rare Diseases Information Center (GARD).
See also  Dihydropyrimidine dehydrogenase deficiency

Tests Listed in the Genetic Testing Registry

Genetic testing plays a crucial role in diagnosing various conditions and disorders related to the COG5 gene. The Genetic Testing Registry (GTR) provides a comprehensive list of tests available for these conditions.

The COG5 gene, also known as Component of Oligomeric Golgi Complex 5, is associated with a rare genetic disorder called COG5-Congenital Disorders of Glycosylation (COG5-CDG). This disorder affects the glycosylation process in the Golgi apparatus, leading to abnormal protein production.

The GTR provides information on the tests available for COG5-related conditions, including COG5-CDG. These tests can detect changes or variants in the COG5 gene and provide valuable diagnostic insights.

The GTR lists various tests for COG5-related conditions, including:

  • Clinical Testing: This type of testing involves analyzing the COG5 gene for known variants associated with the disorder. It helps in confirming a diagnosis and providing information for genetic counseling.
  • Research Testing: Research-based tests focus on understanding the genetic changes and their impact on the disorder. These tests contribute to scientific articles and further knowledge in the field.

In addition to the GTR, there are other resources available for information on COG5-related conditions:

  • Orphanet: Orphanet is a database providing information on rare diseases and orphan drugs. It includes detailed information on COG5-CDG and other related conditions.
  • OMIM: Online Mendelian Inheritance in Man (OMIM) is a comprehensive catalogue of human genes and genetic disorders. Information related to COG5 and its associated disorders can be found in OMIM.
  • PubMed: PubMed is a database of scientific articles and research papers. Searching for “COG5” or “COG5-CDG” in PubMed can yield additional scientific references and articles.

The GTR serves as a valuable resource for both researchers and healthcare professionals seeking information about genetic tests for COG5-related conditions. It helps in the diagnosis, management, and treatment of these rare disorders.

Scientific Articles on PubMed

COG5 gene, also known as conserved oligomeric Golgi complex subunit 5, plays a critical role in protein glycosylation. Mutations in the COG5 gene can lead to COG5-congenital disorder of glycosylation (COG5-CDG), a rare genetic condition that affects the Golgi complex and impairs protein glycosylation.

Scientific articles related to COG5 gene and COG5-CDG can be found in PubMed, a database of scientific literature. PubMed is a valuable resource for finding information about various genetic conditions and related genes.

Some of the articles listed in PubMed provide insights into the genetic changes associated with COG5-CDG and other rare glycosylation disorders. They offer information on diagnostic testing, variant classification, and the clinical presentation of these disorders.

By searching for “COG5” or “COG5-congenital disorder of glycosylation” on PubMed, researchers and healthcare professionals can access a wealth of scientific articles on the topic. These articles can aid in understanding the underlying mechanisms of COG5-related diseases and guide the development of diagnostic tests and treatments.

Furthermore, PubMed provides references to additional resources, such as the COG-CDG Registry and the Orphanet database. These resources offer further information on COG5-CDG, related genes, and associated conditions. The COG-CDG Registry serves as a catalog of genetic variants and clinical features, while Orphanet provides comprehensive information on rare diseases and their management.

In conclusion, PubMed is a valuable tool for accessing scientific articles on COG5 gene and related disorders. It provides researchers and healthcare professionals with a wealth of information to further investigate and understand COG5-CDG and other glycosylation disorders.

Catalog of Genes and Diseases from OMIM

The Catalog of Genes and Diseases (OMIM) is a scientific database that provides comprehensive information on genetic disorders and their associated genes. It is an invaluable resource for researchers, healthcare professionals, and individuals interested in understanding the genetic basis of various conditions.

See also  PLEC gene

The OMIM database contains detailed information on thousands of genes and their associated diseases. It provides a wealth of knowledge on the genetic variations, clinical manifestations, and molecular mechanisms underlying these disorders. For instance, the database includes an article on the COG5 gene, which is associated with the rare genetic disorder known as COG5-Congenital Disorder of Glycosylation (COG5-CDG).

In the OMIM database, the COG5 gene is listed as a causative gene for COG5-CDG. This disorder is characterized by abnormal glycosylation, a process essential for the proper function of proteins in the Golgi apparatus. The COG5-CDG condition can present with a variety of symptoms, including developmental delay, intellectual disability, and skeletal abnormalities.

When researching a specific gene or disorder in the OMIM database, additional resources such as PubMed and Orphanet can be accessed for further scientific articles and information. These resources provide comprehensive references related to the genes and diseases of interest.

In addition to the scientific articles and databases, OMIM also provides a catalog of genes and diseases. This catalog includes the official gene names, alternative gene names, and the associated diseases for each gene. It is a valuable tool for researchers and healthcare professionals who are studying or testing for rare genetic conditions.

Overall, the Catalog of Genes and Diseases from OMIM provides a wealth of genetic information and resources for understanding various health conditions. Researchers and healthcare professionals can access the database to explore the genes and diseases they are interested in, review scientific articles, and find related references. The catalog is a comprehensive compilation of genetic knowledge that aids in the understanding and testing of rare genetic disorders.

Gene and Variant Databases

In the context of the COG5 gene, there are several databases and resources available to access information related to the genetic variants and conditions associated with this gene.

One of the main resources is the Online Mendelian Inheritance in Man (OMIM) database. This database provides comprehensive information on genetic conditions, including COG5-congenital disorder of glycosylation (COG5-CDG) and other related conditions. OMIM lists the gene name, COG5, as well as additional information on the disorder and genetic changes.

Another valuable resource is the Orphanet database, which focuses on rare diseases and orphan drugs. It provides information on the clinical features, testing, and prevalence of COG5-CDG and other related disorders.

The PubMed database is a scientific literature repository that contains articles and references on various topics, including genetic disorders. Searching for “COG5 gene” or related terms on PubMed can provide access to research articles and findings related to the gene and its role in health and disease.

In addition to these databases, there are variant and gene-specific databases that provide more specific information on genetic variants and their consequences. The COG5 Gene Variant Catalog, for example, catalogues the specific variants found in the COG5 gene, along with their associations and clinical significance.

Other resources that provide information on genes and genetic variants include the Genetic Testing Registry (GTR) and the Human Gene Mutation Database (HGMD). These databases offer information on genetic tests available for COG5 and related genes, as well as the associated variants and their clinical significance.

Overall, these databases and resources serve as valuable sources for researchers, clinicians, and individuals seeking information on the COG5 gene, its variants, and the associated genetic conditions. They provide access to scientific literature, variant catalogs, genetic testing information, and other relevant data, aiding in the understanding and diagnosis of COG5-related disorders.

References